New American Academy of Neurology study. Bottom line: MS drugs cost too much, and we really don't know if they do anything to slow the progression of MS.


Study: MS Drugs Help, But Come at High Cost
www.aan.com
A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms of MS and compared to treatments for other chronic diseases. The resear